| |
 |
|
Class Information
Number: 514/177
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Cyclopentanohydrophenanthrene ring system doai > Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system
Description: Subject matter wherein a nuclear carbon of the cyclopentanohydrophenanthrene nucleus is bonded to an oxygen atom through a double bond (C=O).
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5610151 |
Monomeric bile acid derivatives, processes for their preparation and the use of these compounds as medicaments |
Mar. 11, 1997 |
| 5610152 |
Anti-obesity agent 4-cholesten-3-one |
Mar. 11, 1997 |
| 5604214 |
Reduction of boar odor in meat |
Feb. 18, 1997 |
| 5595985 |
Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
Jan. 21, 1997 |
| 5593981 |
Method and treatment of androgen-related diseases |
Jan. 14, 1997 |
| 5591733 |
Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
Jan. 7, 1997 |
| 5587369 |
Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
Dec. 24, 1996 |
| 5587368 |
Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injury |
Dec. 24, 1996 |
| 5583128 |
Contraception in female primates without affecting the menstrual cycle |
Dec. 10, 1996 |
| 5578588 |
Medicament for increasing the testosterone level |
Nov. 26, 1996 |
| 5574022 |
Method of attenuating physical damage to the spinal cord |
Nov. 12, 1996 |
| 5567695 |
Methods for preventing and treating osteoporosis with low dose non-masculinizing androgenic compounds |
Oct. 22, 1996 |
| 5565443 |
Subcutaneous implants based on normegestrol derivatives |
Oct. 15, 1996 |
| 5563131 |
Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
Oct. 8, 1996 |
| 5561124 |
17-.alpha.-acyl steroids which inhibit 5-.alpha.-reductase |
Oct. 1, 1996 |
| 5554595 |
Selective regulation of B lymphocyte precursors by hormones |
Sep. 10, 1996 |
| 5550120 |
Regulating neuropeptide hormone secretion |
Aug. 27, 1996 |
| 5545634 |
Activation of androgen receptors with low dose non-masculinizing androgenic compounds |
Aug. 13, 1996 |
| 5545635 |
Inhibiting bone loss with equilenin |
Aug. 13, 1996 |
| 5541172 |
Controlled release systems and low dose androgens |
Jul. 30, 1996 |
| 5525349 |
Compositions and methods for treating the cornea inconjunction with laser irradiation |
Jun. 11, 1996 |
| 5523298 |
Progestationally active 19,11-bridged 4-estrenes |
Jun. 4, 1996 |
| 5514673 |
Pharmaceutical composition containing lipophilic drugs |
May. 7, 1996 |
| 5514667 |
Method for topical treatment of herpes infections |
May. 7, 1996 |
| 5512556 |
Use of a pregnane derivative |
Apr. 30, 1996 |
| 5510341 |
Ovulation-inhibiting preparation for hormonal contraception |
Apr. 23, 1996 |
| 5505942 |
Use of hydrolytic enzymes for the prophylaxis of spontaneous abortion in pregnant women with habitual idiopathic abortion in their anamneses |
Apr. 9, 1996 |
| 5504074 |
Estrogenic compounds as anti-angiogenic agents |
Apr. 2, 1996 |
| 5502044 |
Fluorinated 4-aminoandrostadienone derivatives and process for their preparation |
Mar. 26, 1996 |
| 5496556 |
Method of treating prostatic adenocarcinoma |
Mar. 5, 1996 |
| 5494899 |
Selective regulation of B lymphocyte precursors by hormones |
Feb. 27, 1996 |
| 5494907 |
11-.beta. substituted-19-nor steroids |
Feb. 27, 1996 |
| 5486511 |
4-amino-17.beta.-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17.beta.-(cyclopropylamino)androst-4-en-3-one and related compounds as C.sub.17-20 lyase and 5.alpha.-reductase |
Jan. 23, 1996 |
| 5480913 |
Anti-androgen compounds |
Jan. 2, 1996 |
| 5446036 |
13-alkyl-11beta-phenylgonanes |
Aug. 29, 1995 |
| 5436237 |
Method of using 4-amino-.DELTA..sup.4 -steroids in the treatment of benign prostatic hyperplasia |
Jul. 25, 1995 |
| 5434146 |
Controlled release systems and low dose androgens |
Jul. 18, 1995 |
| 5420121 |
Use of 4-cholesten-3-one as an anti-obesity agent |
May. 30, 1995 |
| 5413996 |
Targeted drug delivery via phosphonate derivatives |
May. 9, 1995 |
| 5407927 |
Treatment of mild depression and restoration of IGF-I levels in aging by dehydroepiandrosterone |
Apr. 18, 1995 |
| 5401509 |
Pharmaceutical compositions and methods of treatment of the cornea in conjunction with laser irradiation |
Mar. 28, 1995 |
| 5376652 |
Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injury |
Dec. 27, 1994 |
| 5376641 |
Method for making a steroid water soluble |
Dec. 27, 1994 |
| 5372996 |
Method of treatment of androgen-related diseases |
Dec. 13, 1994 |
| 5371078 |
Angiostatic steroids and methods and compositions for controlling ocular hypertension |
Dec. 6, 1994 |
| 5371077 |
Side chain derivatized 15-oxygenated sterols, methods of using them and a process for preparing them |
Dec. 6, 1994 |
| 5364847 |
Inhibitors of sex steroid biosynthesis and methods for their production and use |
Nov. 15, 1994 |
| 5362720 |
Methods of treating or preventing breast or endometrial cancer with low dose non-masculinizing androgenic compounds |
Nov. 8, 1994 |
| 5340805 |
Danazol for treatment of urinary incontinence |
Aug. 23, 1994 |
| 5318961 |
4-amino-.DELTA.4-steroids and their use as 5.alpha.-reductase inhibitors |
Jun. 7, 1994 |
|
|
|
